🔎 Trials Near Me

Akèy › Melanom › Kentucky › Lexington

Etid klinik pou Melanom nan Lexington, KY

10 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Lexington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington
  • Saint Joseph Radiation Oncology Resource Center, Lexington
  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Ap rekriteFaz 3
  • Markey Cancer Center Clinical Research Organization, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06246916

Pan-tumor MRD Study

Ap rekriteEtid obsèvasyon
  • Baptist Health Lexington, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Ap rekriteFaz 3
  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington
  • Saint Joseph Radiation Oncology Resource Center, Lexington
  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
  • ak 1 plis
Laj 75 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07068074

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Ap rekriteFaz 1/2
  • University of Kentucky/Markey Cancer Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05896839

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • University of Kentucky/Markey Cancer Center, Lexington
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Ap rekriteFaz 1/2
  • University of Kentucky, Lexington
Laj 18 a 90 · Tout sèks · Mizajou Jun 10, 2026 · NCT05655312

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Saint Joseph Hospital East, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Ap rekriteFaz 1
  • Markey Cancer Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT04903119

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • University of Kentucky, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Melanom nan lòt vil

Lòt etid nan Lexington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.